Testing effectiveness (Phase 2)Active Not RecruitingNCT03368963
What this trial is testing
TAS102 in Combination With NAL-IRI in Advanced GI Cancers
Who this might be right for
Colorectal AdenocarcinomaGastric AdenocarcinomaMetastatic Pancreatic Adenocarcinoma+11 more
Emory University 64